Benchmark Holdings Finalizes Sale of Aqua Genetics Division
Benchmark Holdings has completed the sale of its Benchmark Genetics, Benchmark Genetics Norway units to Novo Holdings' Starfish Bidco.
The aquaculture biotechnology company sold the business area for £260 million (approximately €310 million), comprising an initial payment of £230 million (approximately €275 million) and a contingent consideration of £30 million (approximately €35 million).
The deal was disclosed in November 2024.
To Read Full Story Login Below.